Exclusive Webinars for Attendees - COVID-19



Firstly, thank you so much for your understanding with our postponement to Sep 27 – 29, with the WHO declaring this novel coronavirus as a  pandemic , we feel it’s our duty to still share, engage and educate our community on SARS-CoV-2.


We invite you to still join us over April 7 – 9 for three key speakers providing three webinar presentations that cover the background of the virus, the spread and our response so far.


Moderated by  Dr Philip Krause,  Deputy Director, OVRR, CBER,  FDA


Tuesday, April 7 at 11 AM EST

SARS-CoV-2:  Going Viral

Dr Gregory A. Poland,  Director of Mayo Vaccine Research Group,  Mayo Clinic

Followed by live Q&As

Register HERE

Webinar ID: 280-819-363



Wedensday, April 8 at 11 AM EST

Coronaviruses in Livestock: Vaccines and International Transport of Virus

Dr Mark Kehrli,  Center Director , National Animal Disease Center

Followed by live Q&As

Register HERE

Webinar ID: 644-129-491


Thursday, April 9 at 11 AM EST

COVID-19: A prototype pathogen demonstration project for pandemic preparedness

Dr Barney S. Graham , Deputy Director, VRC, NIAID , NIH

Followed by live Q&As

Register HERE

Webinar ID: 275-225-547


Make sure to keep these time and dates in your calendar. Each presentation will be 30 min followed up  Q&As  where you are able to write in,  Live!  The full duration will be between 45 min – 60 min.



We would also like to take this opportunity to thank our partner  TriLink Biotechnologies  for supporting these Webinars.


Founded in 1996, TriLink BioTechnologies is a global leader in the synthesis of custom RNA, DNA, NTPs and oligonucleotides used throughout the genomics industry.

TriLink’s highly modified nucleic acid products are instrumental in the fields of vaccine development, gene and oligonucleotide therapy, gene editing and molecular diagnostics.

The company is ISO 9001:2015 certified and operates multiple cGMP suites for manufacturing high-quality nucleic acids in a newly built 100,000 square foot facility in San Diego. 

TriLink Biotech